L A Kalish

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome

P Mauch, L A Kalish, K. J. Marcus et al. · Blood · 1996 · 193 citations · Full text

Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.

P Mauch, L A Kalish, Karen Marcus et al. · PubMed · 2006 · 138 citations

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.

Michael A. Lew, Kathleen Kehoe, Justin Ritz et al. · Journal of Clinical Oncology · 1995 · 87 citations

CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?

Paul C. Stomper, L A Kalish, Marc B. Garnick et al. · Radiology · 1991 · 44 citations

Primary Testicular Tumor, Tumoral Pathology, Genitourinary Cancer +12

Appropriate endpoints for superficial bladder cancer clinical trials.

L A Kalish, Marc B. Garnick, John P. Richie · Journal of Clinical Oncology · 1987 · 32 citations

Invasive Disease Endpoints, Urogenital Radiology, Urological Research +11